JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Global Partners
GLP
$1.57B
| $12.8M | ﹤0.01% |
411,363
-158,268
| -28% | -$5.35M |
2014 Q4
33 quarters
|
|
1977
CALL
Bristol-Myers Squibb
BMY
$120B
| $12.8M | ﹤0.01% |
184,100
-294,100
| -62% | -$20.7M |
2015 Q3
30 quarters
|
|
|
OSG
1978
Octave Specialty Group
OSG
$206M
| $12.7M | ﹤0.01% |
823,450
+707,991
| +613% | +$11.5M |
2013 Q2
39 quarters
|
|
1979
Werner Enterprises
WERN
$2.05B
| $12.7M | ﹤0.01% |
280,058
+19,310
| +7% | +$877K |
2014 Q4
33 quarters
|
|
1980
Vanguard Consumer Staples ETF
VDC
$7.54B
| $12.7M | ﹤0.01% |
65,771
+5,401
| +9% | +$1.02M |
2015 Q4
29 quarters
|
|
1981
Valley National Bancorp
VLY
$7.05B
| $12.7M | ﹤0.01% |
1,375,291
+354,336
| +35% | +$3.92M |
2013 Q2
39 quarters
|
|
1982
CALL
Hilton Worldwide
HLT
$71.1B
| $12.7M | ﹤0.01% |
90,000
+85,100
| +1,737% | +$12M |
2022 Q2
3 quarters
|
|
1983
PUT
Hewlett Packard
HPE
$90.7B
| $12.7M | ﹤0.01% |
795,800
+351,800
| +79% | +$5.53M |
2022 Q1
4 quarters
|
|
1984
Runway Growth Finance
RWAY
$270M
| $12.7M | ﹤0.01% |
+1,044,543
| New | +$13.1M |
2023 Q1
0 quarters
|
|
1985
PagSeguro Digital
PAGS
$3.02B
| $12.7M | ﹤0.01% |
1,477,417
+882,961
| +149% | +$7.89M |
2018 Q1
20 quarters
|
|
1986
Iovance Biotherapeutics
IOVA
$6.41B
| $12.6M | ﹤0.01% |
2,069,371
-266,749
| -11% | -$1.84M |
2017 Q2
23 quarters
|
|
1987
Brookfield Infrastructure
BIPC
$4.47B
| $12.6M | ﹤0.01% |
274,304
+4,783
| +2% | +$208K |
2020 Q2
11 quarters
|
|
1988
State Street Materials Select Sector SPDR ETF
XLB
$7.87B
| $12.6M | ﹤0.01% |
313,200
-55,262
| -15% | -$2.24M |
2013 Q2
39 quarters
|
|
1989
Xerox
XRX
$397M
| $12.6M | ﹤0.01% |
819,673
-1,078,586
| -57% | -$17.4M |
2013 Q2
39 quarters
|
|
1990
Element Solutions
ESI
$9.15B
| $12.6M | ﹤0.01% |
652,029
+80,974
| +14% | +$1.6M |
2015 Q4
29 quarters
|
|
1991
PUT
Charter Communications
CHTR
$12.3B
| $12.6M | ﹤0.01% |
35,200
-95,600
| -73% | -$35.7M |
2019 Q1
16 quarters
|
|
1992
Celsius Holdings
CELH
$6.96B
| $12.6M | ﹤0.01% |
405,336
+106,059
| +35% | +$3.35M |
2018 Q2
19 quarters
|
|
1993
Rithm Capital
RITM
$4.88B
| $12.5M | ﹤0.01% |
1,567,824
+659,560
| +73% | +$5.8M |
2013 Q2
39 quarters
|
|
1994
Cytokinetics
CYTK
$8.72B
| $12.5M | ﹤0.01% |
356,070
+44,872
| +14% | +$1.83M |
2017 Q4
21 quarters
|
|
1995
Vanguard International High Dividend Yield ETF
VYMI
$21B
| $12.5M | ﹤0.01% |
202,223
+16,857
| +9% | +$1.05M |
2018 Q1
20 quarters
|
|
1996
PUT
CME Group
CME
$97.1B
| $12.5M | ﹤0.01% |
65,300
+22,400
| +52% | +$4.05M |
2017 Q4
21 quarters
|
|
1997
CALL
Mondelez International
MDLZ
$74.7B
| $12.5M | ﹤0.01% |
179,100
+69,600
| +64% | +$4.61M |
2021 Q2
7 quarters
|
|
1998
MSC Industrial Direct
MSM
$7.27B
| $12.5M | ﹤0.01% |
148,647
+14,045
| +10% | +$1.16M |
2013 Q2
39 quarters
|
|
|
NEE.PRQ
1999
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $12.5M | ﹤0.01% |
255,459
+215,146
| +534% | +$10.4M |
2020 Q3
10 quarters
|
|
2000
PUT
Williams Companies
WMB
$86.6B
| $12.5M | ﹤0.01% |
417,800
+215,500
| +107% | +$6.66M |
2022 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.